Frank Morich
Chairman at CUE BIOPHARMA, INC.
Net worth: 39 480 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Frances L. Johnson | M | - |
Viewpoint Molecular Targeting, Inc.
 Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | 16 years |
| Cameron Gray | M | 53 |
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | 8 years |
| Daniel Passeri | M | 63 | 8 years | |
| Mark Austin | M | 37 | 7 years | |
| Irina Staatz-Granzer | M | 64 | 15 years | |
| Johan Spoor | M | 52 |
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | 2 years |
| Aram Andrew Mangasarian | M | 54 |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | 14 years |
| Kerri-Ann Millar | F | 54 | 7 years | |
| Peter Kiener | M | 72 | 8 years | |
| Odile Belzunce | F | 44 | 19 years | |
| Michael K. Schultz | M | - |
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | 16 years |
| Curtis R. Nelson | M | - |
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | - |
| Anish Suri | M | 50 | 6 years | |
| Colin Sandercock | M | 67 | 7 years | |
| Pamela Garzone | M | 69 | 1 years | |
| Krisja Vermeylen | F | 62 | 7 years | |
| Marie Campinell | F | - | - | |
| Fred Driscoll | M | 74 | 6 years | |
| Olivier Martinez | M | 54 | 14 years | |
| Gilles Brisson | M | 72 | 17 years | |
| Patrick Verheyen | M | 64 | 1 years | |
| Michael Brosnan | M | 69 | 6 years | |
| Markus Puhlmann | M | - | - | |
| Christopher O'Reilly | M | - | 13 years | |
| Ann Merchant | F | 59 | 6 years | |
| Heidi Henson | F | 58 | 1 years | |
| Matteo Levisetti | M | 55 | 3 years | |
| Lori Woods | F | 61 | 1 years | |
| Robert Williamson | M | 58 | 1 years | |
| Heike Hausfeld | F | 58 | 30 years | |
| Jonathan Hunt | M | 57 | 1 years | |
| Sharon Curran | F | 56 | 5 years | |
| Thomas Raffin | M | 77 |
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | - |
| Christiaan de Wilde | M | - |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | 18 years |
| Charles Link | M | 64 |
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | 3 years |
| Jean-Paul Kress | M | 59 | 5 years | |
| Mwana Lugogo | M | 54 | 12 years | |
| George Golumbeski | M | 67 | 6 years | |
| Andrew Bright | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Werner Baumann | M | 60 | 35 years | |
| Iwaaki Taniguchi | M | - | - | |
| Shiro Kuniya | M | 67 | - | |
| Barry Simon | M | 59 | - | |
| Rodolfo J. Chaparro | M | - | 7 years | |
| Bernd Metzner | M | 53 | 4 years | |
| Fumio Sudo | M | 83 | 6 years | |
| Claudia Gutjahr-Löser | M | - | - | |
| Roland Wandeler | M | 51 | 1 years | |
| François-Xavier Roger | M | 62 | 2 years | |
| Anke Linnartz | F | 54 | - | |
| Deborah Dunsire | M | 61 | 3 years | |
| Richard Pott | M | 71 | 29 years | |
| Jennifer Streeter | F | 55 | - | |
| Ronald D. Seidel | M | - | 8 years | |
| Stéphane Boissel | M | 56 | 8 years | |
| Steven McKnight | M | 75 | 4 years | |
| Markus Enzelberger | M | 55 | 18 years | |
| Aaron Fletcher | M | 44 | 4 years | |
| Malte Peters | M | 61 | 5 years | |
| Laure-Hélène Mercier | F | 46 | 14 years | |
| Gerald Heinz Möller | M | 80 | 19 years | |
| Klaus Kühn | M | 72 | 3 years | |
| Tamar Howson | F | 75 | 3 years | |
| Walter Blättler | M | 75 | 8 years | |
| Marcel Rozencweig | M | 78 | 8 years | |
| Karin Eastham | F | 74 | 5 years | |
| Patrick J. Langlois | M | 78 | 12 years | |
| Paul Magrez | M | - |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | 6 years |
| Simon Moroney | M | 65 | 27 years | |
| Geoffrey Nicholas Vernon | M | 72 | 16 years | |
| Yorihiko Kojima | M | 82 | - | |
| Daniel Camus | M | 70 | 12 years | |
| Wendy Johnson | F | 72 | 7 years | |
| Karl-Ludwig Kley | M | 72 | 16 years | |
| Tadataka Yamada | M | 77 | 4 years | |
| Rolf Hoffmann | M | 48 | - | |
| Tom Harris | M | - | 7 years | |
| Jörg Möller | M | - | 27 years | |
| Jamie Dananberg | M | 66 | 3 years | |
| Timothy Sullivan | M | 54 | 3 years | |
| Lodewijk Christian van Wachem | M | 92 | - | |
| William Carson | M | 76 | 8 years | |
| John-Edward Butler-Ransohoff | M | - | 10 years | |
| Christa Kreuzburg | M | 65 | 17 years | |
| Manuela Strauch | F | 52 | - | |
| Richard van der Merwe | M | - | - | |
| Thomas Hoffmann | M | 53 | - | |
| Dariusz Adam Bak | M | 55 | 4 years | |
| Colin Foster | M | 61 | 10 years | |
| Yoshiaki Nomura | M | - | - | |
| Thomas Fischer | M | 68 | - | |
| Christoph Petry | M | - | 13 years | |
| Pol Bamelis | M | 85 | 36 years | |
| Holger Zimmermann | M | - | 6 years | |
| Stephan Friedhelm Gerlich | M | 65 | - | |
| Manfred Schneider | M | 85 | 28 years | |
| Barthold Piening | M | 66 |
Takeda Pharmaceuticals International AG
 Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | 3 years |
| Douglas Liu | M | 62 | 9 years | |
| An Bang Lu | M | 58 | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Germany | 43 | 43.43% |
| United States | 31 | 31.31% |
| Japan | 14 | 14.14% |
| France | 8 | 8.08% |
| Belgium | 2 | 2.02% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Frank Morich
- Personal Network
